Dr. Hojun Li

Visiting Scientist

Primary DLC

Koch Institute for Integrative Cancer Research (KIICR)

MIT Room: 76

Areas of Interest and Expertise

Personalized Medicine

Research Summary

Dr. Li’s research at the Koch Institute remains focused on basic hematopoietic stem and progenitor cell biology in both the physiologic and pathologic settings. He aims to develop clinically relevant approaches for both small molecule intervention in leukemia predisposition syndromes, and genetic correction of hematopoietic stem cells.

Recent Work